dr. bekaii-saab on benefits associated with regorafenib or tas-102 for crc
Published 8 years ago • 105 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:50
dr. bekaii-saab on sequencing regorafenib and tas-102 in crc
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
2:24
dr. bekaii saab compares toxicities of regorafenib and tas-102 in colorectal cancer
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
0:20
copy of dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
0:57
dr. bekaii-saab discusses the next steps with regorafenib in crc
-
1:39
dr. bekaii-saab on dosing strategies with regorafenib in crc
-
6:28
朗斯弗 lonsurf tas-102 大腸直腸癌 藥物介紹 鄧豪偉醫師 腸癌即時照護網 crc.uptocare.com
-
7:25
trifluridine tipiracil – lonsurf®
-
3:39
impact of tas-102 in metastatic colorectal cancer - video abstract id 113320
-
2:47
mcrc: sequencing with regorafenib or tas-102
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
2:26
dr. bekaii-saab on the impact of regorafenib in crc
-
2:13
later-line treatment for mcrc: regorafenib or tas-102?
-
2:05
howard s. hochster, md, provides perspective on how to use tas-102 and regorafenib in crc patients
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
7:54
regorafenib vs tas-102 salvage therapy
-
0:57
choosing between tas-102 and regorafenib in colorectal cancer
-
2:13
dr. lenz on the benefit of regorafenib in crc
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
9:06
debate: is there an optimal treatment for refractory colorectal cancer? - tas-102 or regorafenib